Accessibility Menu

Profound Medical

(TSX) PRN

Current PriceCA$9.57
Market CapCA$342.66M
Since IPO (2015)-37%
5 Year-53%
1 Year+16%
1 Month-1%

Profound Medical Financials at a Glance

Market Cap

CA$342.66M

Revenue (TTM)

$18.76M

Net Income (TTM)

-$38.82M

EPS (TTM)

-CA$1.73

P/E Ratio

-5.46

Dividend

CA$0.00

Beta (Volatility)

1.06 (Average)

Price

CA$9.57

Volume

2,327

Open

CA$9.74

Previous Close

CA$9.43

Daily Range

CA$9.57 - CA$9.74

52-Week Range

CA$5.23 - CA$12.40

Estimated Earnings Date

Jul 30, 2026

PRN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Profound Medical

Industry

Healthcare Equipment and Supplies

Employees

162

CEO

Arun S. Menawat, PhD, EMBA

Headquarters

Mississauga, ON L4W 5K5, CA

PRN Financials

Key Financial Metrics (TTM)

Gross Margin

71.04%

Operating Margin

-202.52%

Net Income Margin

-206.94%

Return on Equity

-78.75%

Return on Capital

-59.11%

Return on Assets

-52.81%

Earnings Yield

-18.32%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$342.66M

Shares Outstanding

36.34M

Volume

2.33K

Avg. Volume

11.94K

Financials (TTM)

Gross Profit

$13.33M

Operating Income

-$37.99M

EBITDA

-$36.45M

Operating Cash Flow

-$38.32M

Capital Expenditure

-$179.08K

Free Cash Flow

-$38.50M

Cash & ST Invst.

$50.33M

Total Debt

$7.47M

Profound Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$5.25M

+100.3%

Gross Profit

$3.77M

+103.4%

Gross Margin

71.80%

N/A

Market Cap

CA$342.66M

N/A

Market Cap/Employee

CA$2.41M

N/A

Employees

142

N/A

Net Income

-$6.94M

+35.3%

EBITDA

-$7.79M

+29.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$50.33M

+8.4%

Total Debt

$7.47M

+52.9%

Accounts Receivable

$9.43M

+58.1%

Inventory

$9.01M

+32.6%

Long Term Debt

$2.89M

-37.4%

Short Term Debt

$4.57M

+618.0%

Return on Assets

-52.81%

N/A

Return on Invested Capital

-60.41%

N/A

Free Cash Flow

-$8.44M

-1.9%

Operating Cash Flow

-$8.44M

-1.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DR.TOMedical Facilities Corporation
CA$18.11+1.17%
NGEN.VNervGen Pharma Corp.
CA$5.15+3.00%
XLY.TOAuxly Cannabis Group Inc.
CA$0.18+2.86%
CRRX.TOCareRx Corporation
CA$3.40-1.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$75.13-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$39.02+0.03%
AALAmerican Airlines Group
$17.97-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.44+0.02%

Questions About PRN

What is the current price of Profound Medical?

Profound Medical is trading at CA$9.57 per share.

What is the 52-week range for Profound Medical?

Over the past 52 weeks, Profound Medical has traded between CA$5.23 and CA$12.40.

How much debt does Profound Medical have?

As of the most recent reporting period, Profound Medical reported total debt of $10.41M.

How much cash does Profound Medical have on hand?

Profound Medical reported $70.19M in cash and cash equivalents in its most recent financial results.

What is Profound Medical’s dividend yield?

Profound Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.